Being tested
Corticosteroids (relapse treatment): reduce relapses and new lesions in relapsing MS
relapsing MS · Corticosteroids (relapse treatment)
Trials are running now and no controlled trial has a readable result yet.
1 trial(s) stopped for safety reasons.
- Trials
- 19
- Running now
- 1
- Controlled phase 2/3 trials
- 2
- People in controlled trials
- 102
No controlled trial has reported a result yet.
Other linked trials: 19
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 19
These linked trials do not set the status.
- NTZ2TTYNo result found
Phase 4 · 2019 · Placebo-controlled
- OPTIONSStopped: safety
Phase 4 · 2017 · Placebo-controlled
- Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in RelapseResult in a paper, not read yet
Phase 4 · 2013 · Not randomised
- Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS ExacerbationsNo result found
Phase 4 · 2013 · Not randomised
- AVONEX® Combination Trial - "ACT"No result found
Phase 4 · 2003 · Not randomised
- MECOMBINResult in a paper, not read yet
Phase 4 · 2003 · Placebo-controlled
- MOSTStopped, other reason
Phase 3 · 2017 · Not randomised
- Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis AttacksStopped, other reason
Phase 3 · 2003 · Not randomised
- IN-DXM-EMRROngoing
Phase 2 · 2023 · Not randomised
- Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple SclerosisNo result found
Phase 2 · 2021 · Placebo-controlled
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as Being tested
Related hypotheses
- Corticosteroids (relapse treatment): prevent attacks in NMOSD
- Corticosteroids (relapse treatment): reduce relapses and new lesions in optic neuritis
- Corticosteroids (relapse treatment): reduce relapses and new lesions in primary progressive MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in relapsing and progressive MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in secondary progressive MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in MS (type not specified)
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error